Privium Fund Management B.V. - CLARUS THERAPEUTICS HLDNGS I ownership

Back to all holdings Add to watchlist

CLARUS THERAPEUTICS HLDNGS I's ticker is and the CUSIP is 18271L115. A total of 5 filers reported holding CLARUS THERAPEUTICS HLDNGS I in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
Privium Fund Management B.V. ownership history of CLARUS THERAPEUTICS HLDNGS I
ValueSharesWeighting
Q2 2022$13,000
-69.0%
163,0300.0%0.00%
-50.0%
Q4 2021$42,000–163,030–0.01%–
 Download
Other shareholders

There were no reported owners of CLARUS THERAPEUTICS HLDNGS I in Q3 2022.

NameSharesValueWeighting ↓
View complete list of CLARUS THERAPEUTICS HLDNGS I shareholders